666 related articles for article (PubMed ID: 18564492)
1. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
Rai AK; Reichman JH; Uhlir PF; Crossman C
Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
[No Abstract] [Full Text] [Related]
2. Science and the law. Working through the patent problem.
Walsh JP; Cohen WM; Arora A
Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
[No Abstract] [Full Text] [Related]
3. Industry and academia in transition.
Kennedy D
Science; 2003 Nov; 302(5649):1293. PubMed ID: 14631000
[No Abstract] [Full Text] [Related]
4. Perestroika in pharma: evolution or revolution in drug development?
FitzGerald GA
Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
[TBL] [Abstract][Full Text] [Related]
5. New ethical requirements at the NIH: implications for CIHR and Canada.
Bernstein A
CMAJ; 2005 Aug; 173(4):353-4. PubMed ID: 16103503
[No Abstract] [Full Text] [Related]
6. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
7. An audience with...Francis Collins. Interviewed by Asher Mullard.
Collins F
Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
[No Abstract] [Full Text] [Related]
8. Trust, but verify.
Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
[No Abstract] [Full Text] [Related]
9. The SNP consortium: summary of a private consortium effort to develop an applied map of the human genome.
Holden AL
Biotechniques; 2002 Jun; Suppl():22-4, 26. PubMed ID: 12083393
[No Abstract] [Full Text] [Related]
10. Public-private partnerships at the National Institutes of Health: from discovery to commercialization.
Lyles A
Clin Ther; 2003 Nov; 25(11):2900-2. PubMed ID: 14693314
[No Abstract] [Full Text] [Related]
11. Regulating scientific research: intellectual property rights and the norms of science.
Rai AK
Northwest Univ Law Rev; 1999; 94(1):77-152. PubMed ID: 12784815
[No Abstract] [Full Text] [Related]
12. U.S. research funding. Industry shrinks academic support.
Bhattacharjee Y
Science; 2006 May; 312(5774):671. PubMed ID: 16675669
[No Abstract] [Full Text] [Related]
13. Molecular medicine. NIH dives into drug discovery.
Couzin J
Science; 2003 Oct; 302(5643):218-21. PubMed ID: 14551416
[No Abstract] [Full Text] [Related]
14. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
15. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
16. NIH Molecular Libraries Initiative.
Austin CP; Brady LS; Insel TR; Collins FS
Science; 2004 Nov; 306(5699):1138-9. PubMed ID: 15542455
[No Abstract] [Full Text] [Related]
17. Private sector contributions to pharmaceutical science: thirty-five summary case histories.
Zycher B; DiMasi JA; Milne CP
Am J Ther; 2010; 17(1):101-20. PubMed ID: 20027102
[TBL] [Abstract][Full Text] [Related]
18. Genomic capital: public cultures and market logics of corporate biotechnology.
Rajan KS
Sci Cult (Lond); 2003 Mar; 12(1):87-121. PubMed ID: 15971369
[No Abstract] [Full Text] [Related]
19. Intellectual property rights. Public sector collaboration for agricultural IP management.
Atkinson RC; Beachy RN; Conway G; Cordova FA; Fox MA; Holbrook KA; Klessig DF; McCormick RL; McPherson PM; Rawlings HR; Rapson R; Vanderhoef LN; Wiley JD; Young CE
Science; 2003 Jul; 301(5630):174-5. PubMed ID: 12855794
[No Abstract] [Full Text] [Related]
20. For sale: The Framingham Heart Study.
Ready T
Nat Med; 2000 Jul; 6(7):721. PubMed ID: 10888896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
